Phentermine for Childhood Obesity

(PhITT Trial)

This trial tests the effectiveness and safety of phentermine, a medication for treating obesity in adolescents. Participants will receive either phentermine or a placebo (a pill with no active ingredients) for one year to assess its impact on weight loss. Researchers aim to determine if phentermine can effectively complement lifestyle changes in managing obesity. Adolescents aged 12 to under 18 with obesity, who have not recently used certain medications, may qualify for this study. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to important findings in obesity management.

Studies have shown that phentermine is generally safe for children and teenagers. One report found no serious side effects when phentermine was used, with the most common issues being mild stomach problems, such as an upset stomach. Another study found that over 60% of young people taking phentermine lost more than 5% of their body weight after six months, with no major safety concerns.

Most treatments for childhood obesity focus on lifestyle changes, like diet and exercise, or medications that alter appetite and fat absorption. But phentermine stands out because it acts as an appetite suppressant by stimulating the central nervous system, similar to how it affects adults with obesity. Researchers are excited about phentermine because it has the potential to provide a pharmacological option specifically tailored for adolescents, offering a new avenue beyond the traditional lifestyle modifications. If successful, it could be a game-changer for young individuals struggling with obesity, providing them with an effective tool to manage their weight more proactively.

Research has shown that phentermine can help teenagers with obesity lose weight. One study found that 40% of participants taking phentermine lost more than 5% of their body weight in just three months, with over 60% reaching this goal by six months. Another study discovered that phentermine, often combined with other medications like topiramate, helped most patients lower their Body Mass Index (BMI, a measure of body fat based on height and weight) over 3 to 12 months. In this trial, participants in the Phentermine 16 mg Group will receive phentermine to evaluate its efficacy and safety in adolescents with obesity. These findings suggest that phentermine can effectively help young people manage obesity by promoting weight loss.²³⁴⁶⁷